PEOPLE - Credent (UK) makes appointment:
This article was originally published in Clinica
Medical device company Credent (Wrexham, Wales) has appointed Ian Kent as chairman. Mr Kent currently serves as chairman for a number of venture capital funded biopharma companies. It has also announced the appointments of Malcom Boddy as managing director of Credent Vascular Technologies and Rod Ruston as regulatory affairs director. Mr Boddy, who has over 40 years in the medical device and pharmaceutical industries, has served several companies including Smith & Nephew and Baxter Healthcare. Mr Ruston will maintain his responsibilities as director of Priory Analysts.
You may also be interested in...
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.